Introduction
HPV-related cancers
HUMAN PAPILLOMAVIRUS
Human papillomavirus (HPV) vaccines are highly effective against cervical and other HPV-related cancers, while being safe and generating population immunity [Previous studies suggest that the main barriers to HPV vaccination in France are lack of parental awareness and low perceived accessibility, combined with widespread doubts on the need and safety of the vaccine [As in other countries [A systematic review suggested that young adolescents, the target group for HPV vaccination in most countries, have relatively favourable attitudes towards HPV vaccination, but lack awareness [In this context, we aimed to delineate socio-educational inequalities of HPV vaccine awareness, self-reported uptake and vaccination intention among French adolescents aged 13–15 years, and to investigate whether visits to the family GP and school lessons on vaccination could mitigate these inequalities.